This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
Grants paid by year
Total assets by year
Where the money went · FY2024
Form 990 splits expenses into program services, management and fundraising. The split is self-reported, and a grantmaker, a research institute and a direct-service nonprofit book the same work differently. A line the return does not carry reads "not available"; it is never counted as zero.
| Year | Form | Revenue | Expenses | Grants paid | Assets | Net assets |
|---|---|---|---|---|---|---|
| FY2024 | 990 | $49,306,331 | $56,828,646 | $12,782,246 | $51,274,531 | $8,640,440 |
| FY2023 | 990 | $90,612,477 | $96,117,239 | $35,829,203 | $81,417,302 | $16,162,755 |
| FY2022 | 990 | $144,248,069 | $146,186,498 | $87,636,841 | $137,542,319 | $21,667,517 |
| FY2021 | 990 | $110,032,140 | $95,593,710 | $48,933,103 | $189,507,117 | $22,044,318 |
| FY2020 | 990 | $98,212,578 | $91,124,840 | $47,562,253 | $107,298,970 | $12,986,212 |
Figures are as reported on the e-filed return, with no restatement. Fiscal years are the funder's own tax year, labelled by the calendar year the period ends in. A blank line means the return does not carry that figure; a real zero shows as $0. When an amended return replaces an original, every figure here uses the amended return. The original is not shown. Giving is what the funder actually paid out toward its charitable purpose in the year (qualifying distributions on Form 990-PF, charitable disbursements otherwise). Assets are what it holds; giving is what moves.
Recipient focus areas
Where recipients are
Based on the 50% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| Transnational TechnologiesIncWindermere, FL | Supportmanufacturingandcommercializationof antigenrdtforcovid | $5,101,000 | 2021 | |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Ayoade Alakija | CHAIRMAN OF THE BOARD | 1.0 | $0 |
| David Heymann | MEMBER OF THE BOARD | 1.0 | $0 |
| Frutiger Christian | MEMBER OF THE BOARD | 1.0 | $0 |
| Kamineni Shobana | MEMBER OF THE BOARD |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| BiomemePhiladelphia, PA |
| Development of diagnostic tests |
| $4,015,000 |
| 2022 |
| DiagnosticConsultingNetworkIncCarlsbad, CA | Developmentofdiagnostictests | $3,977,810 | 2021 |
| Transnational TechnologiesIncWindermere, FL | Supportmanufacturingandcommercializationof antigenrdtforcovid | $3,200,000 | 2022 |
| Diagnostic Consulting Network IncCARLSBAD, CA | Not available | $2,583,053 | 2020 |
| WHO-PAHOWashington, DC | Scaling-uptheuseofcovidantigenrapiddiagnost ic tests in Americas testsinAmericas testsinAmericas | $2,275,676 | 2022 |
| CHAI-ClintonHealthAccessInitiationIncBoston, MA | TosupportTBeliminationefforts | $2,007,458 | 2022 |
| Diagnostic Consulting Network IncCarlsbad, CA | Development of diagnotic tests | $1,012,297 | 2023 |
| DiagnosticConsultingNetworkIncCarlsbad, CA | Developmentofdiagnostictests | $854,249 | 2022 |
| WHO-PAHOWashington, DC | Scaling-uptheuseofcovidantigenrapiddiagnost ic tests in Americas testsinAmericas testsinAmericas | $850,451 | 2021 |
| Elizabeth Glaser Pediatric Aids FoundationWashington, DC | Evaluation of Antigen Rapid Diagnostic Tests | $793,500 | 2022 |
| ColumbiaUniversitynew york, NY | ImplementationofcovidagRDTsinSouthSudan | $792,000 | 2022 |
| CHAI -Clinton Health Access Initiation IncBoston, MA | To support TB elimination efforts | $723,586 | 2023 |
| BiomemePhiladelphia, PA | Development of diagnotic tests | $685,000 | 2023 |
| Boston UniversityBOSTON, MA | Sponsored Research | $655,323 | 2022 |
| UniversityofNorthCarolinaChapelHill, NC | Laboratorystrengtheningtosupportclinicalcare andresearch | $644,191 | 2022 |
| ManagementSciencesforHealthcambridge, MA | Undertake a project in the field of in vitro diagnostics and COVID | $621,481 | 2022 |
| Baylor College of MedicineHouston, TX | Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure. | $548,709 | 2023 |
| University of North CarolinaChapel Hill, NC | Laboratory strengthening to support clinical care and research | $526,828 | 2023 |
| UNIVERSITY OF NORTH CAROLINAChapel Hill, NC | LABORATORY STRENGTHENING TO SUPPORT CLINICAL CARE AND RESEARCH | $506,168 | 2024 |
| DIAGNOSTIC CONSULTING NETWORKCARLSBAD, CA | DEVELOPMENT OF DIAGNOTIC TESTS | $410,848 | 2024 |
| Georgetown UniversityWashington, DC | Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure. | $400,000 | 2023 |
| Drugs&DiagnosticsforTropicalDiseasesSanDiego, CA | Developmentandcommercialisationofdiagnotic tests | $360,186 | 2021 |
| Broad InstituteCambridge, MA | Development of a rapide, point-of-care diagnostic for high sensitivity detection of Tuberculosis | $355,100 | 2023 |
| The Regents of the University of California San Diego School of MedicineLa Jolla, CA | Consulting services and blood culture due diligence support | $338,978 | 2023 |
| 1.0 |
| $0 |
| Marcel Tanner | MEMBER OF THE BOARD | 1.0 | $0 |
| Michele Costaforlaz | MEMBER OF THE BOARD | 1.0 | $0 |
| Precious Matsoso | MEMBER OF THE BOARD | 1.0 | $0 |
| Rick Arthur Bright | MEMBER OF THE BOARD (THRU 8/2024) | 1.0 | $0 |
| Soumya Swaminathan | MEMBER OF THE BOARD (THRU 8/2024) | 1.0 | $0 |
| Cassandra Kelly-Cirino | VP, HEALTH PROGRAMMES (thru 8/24) | 40.0 | $191,471 |
| Dayo Adetifa | CHIEF TRANSFORMATION OFFICER/CEO | 40.0 | $138,966 |
| Marta Fernandez Suarez | CHIEF TECHNOLOGY OFFICER (thru 10/24) | 40.0 | $285,980 |
| Norma Torres | CHIEF OPERATING OFFICER (thru 5/24) | 40.0 | $215,973 |
| Sergio Carmona | CHIEF MEDICAL OFFICER (thru 9/24) | 40.0 | $284,240 |
| Sharon Saacks | SENIOR DIRECTOR, PROGRAMME OPERATIONS (thru 7/24) | 40.0 | $230,858 |
| William Rodriguez | CHIEF EXECUTIVE OFFICER (thru 6/24) | 40.0 | $197,568 |
| Willo Brock | EXECUTIVE VP, EXTERNAL AFFAIRS (thru 6/24) | 40.0 | $163,705 |
| Darryl English | DEPUTY DIRECTOR, FINANCE (THRU 11/24) | 40.0 | $342,536 |
| Kevin Tetteh | DIRECTOR, MALARIA FEVER PROGRAMME | 40.0 | $181,958 |
| Sanjay Sarin | VP, ACCESS (thru 10/24) | 40.0 | $232,372 |
| Beatrice Mouton | DIRECTOR, HUMAN RESOURCES | 40.0 | $260,701 |
| Brooke Nichols | SENIOR DIRECTOR, IMPACT | 40.0 | $265,429 |
| Maria Cecilia Ferreyra Arellano | Director of AMR Programme | 40.0 | $213,012 |
| Morten Ruhwald | DIRECTOR, TUBERCULOSIS PROGRAMME | 40.0 | $244,800 |
| Shaukhat Ali Khan | Director Strategic Information | 40.0 | $235,091 |
| Louisa Chaubert | DIRECTOR OF FINANCE (THRU 12/23) | 0.0 | $95,808 |
Nearest by size, location and giving pattern in the database. Geography weighs heavily. Treat it as a starting list, not a ranking of fit.
Form 990 · FY2023 · period ending Dec 31, 2023IRS bulk XML
Filing id 202433209349311393
Form 990 · FY2022 · period ending Dec 31, 2022
Filing id 202343199349316034
Form 990 · FY2021 · period ending Dec 31, 2021
Filing id 202203199349309895
Form 990 · FY2020 · period ending Dec 31, 2020
Filing id 202113199349315546
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.